PortfoliosLab logo
HRMY vs. PRTH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HRMY and PRTH is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

HRMY vs. PRTH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Harmony Biosciences Holdings, Inc. (HRMY) and Priority Technology Holdings, Inc. (PRTH). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

HRMY:

0.33

PRTH:

1.34

Sortino Ratio

HRMY:

0.71

PRTH:

1.88

Omega Ratio

HRMY:

1.10

PRTH:

1.24

Calmar Ratio

HRMY:

0.25

PRTH:

1.52

Martin Ratio

HRMY:

0.90

PRTH:

4.74

Ulcer Index

HRMY:

14.76%

PRTH:

22.23%

Daily Std Dev

HRMY:

47.19%

PRTH:

88.57%

Max Drawdown

HRMY:

-68.48%

PRTH:

-88.12%

Current Drawdown

HRMY:

-43.80%

PRTH:

-39.14%

Fundamentals

Market Cap

HRMY:

$1.92B

PRTH:

$594.96M

EPS

HRMY:

$2.62

PRTH:

-$0.11

PS Ratio

HRMY:

2.57

PRTH:

0.66

PB Ratio

HRMY:

2.66

PRTH:

0.00

Total Revenue (TTM)

HRMY:

$744.85M

PRTH:

$898.61M

Gross Profit (TTM)

HRMY:

$577.57M

PRTH:

$301.57M

EBITDA (TTM)

HRMY:

$222.47M

PRTH:

$147.94M

Returns By Period

In the year-to-date period, HRMY achieves a -0.52% return, which is significantly higher than PRTH's -36.34% return.


HRMY

YTD

-0.52%

1M

19.06%

6M

3.73%

1Y

15.25%

5Y*

N/A

10Y*

N/A

PRTH

YTD

-36.34%

1M

9.20%

6M

-9.00%

1Y

117.44%

5Y*

38.60%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HRMY vs. PRTH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRMY
The Risk-Adjusted Performance Rank of HRMY is 6161
Overall Rank
The Sharpe Ratio Rank of HRMY is 6565
Sharpe Ratio Rank
The Sortino Ratio Rank of HRMY is 5757
Sortino Ratio Rank
The Omega Ratio Rank of HRMY is 5858
Omega Ratio Rank
The Calmar Ratio Rank of HRMY is 6363
Calmar Ratio Rank
The Martin Ratio Rank of HRMY is 6262
Martin Ratio Rank

PRTH
The Risk-Adjusted Performance Rank of PRTH is 8686
Overall Rank
The Sharpe Ratio Rank of PRTH is 9090
Sharpe Ratio Rank
The Sortino Ratio Rank of PRTH is 8484
Sortino Ratio Rank
The Omega Ratio Rank of PRTH is 8282
Omega Ratio Rank
The Calmar Ratio Rank of PRTH is 9090
Calmar Ratio Rank
The Martin Ratio Rank of PRTH is 8686
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HRMY vs. PRTH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Harmony Biosciences Holdings, Inc. (HRMY) and Priority Technology Holdings, Inc. (PRTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current HRMY Sharpe Ratio is 0.33, which is lower than the PRTH Sharpe Ratio of 1.34. The chart below compares the historical Sharpe Ratios of HRMY and PRTH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Dividends

HRMY vs. PRTH - Dividend Comparison

Neither HRMY nor PRTH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

HRMY vs. PRTH - Drawdown Comparison

The maximum HRMY drawdown since its inception was -68.48%, smaller than the maximum PRTH drawdown of -88.12%. Use the drawdown chart below to compare losses from any high point for HRMY and PRTH. For additional features, visit the drawdowns tool.


Loading data...

Volatility

HRMY vs. PRTH - Volatility Comparison

The current volatility for Harmony Biosciences Holdings, Inc. (HRMY) is 11.67%, while Priority Technology Holdings, Inc. (PRTH) has a volatility of 22.57%. This indicates that HRMY experiences smaller price fluctuations and is considered to be less risky than PRTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

HRMY vs. PRTH - Financials Comparison

This section allows you to compare key financial metrics between Harmony Biosciences Holdings, Inc. and Priority Technology Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20212022202320242025
184.73M
224.63M
(HRMY) Total Revenue
(PRTH) Total Revenue
Values in USD except per share items

HRMY vs. PRTH - Profitability Comparison

The chart below illustrates the profitability comparison between Harmony Biosciences Holdings, Inc. and Priority Technology Holdings, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20212022202320242025
82.7%
38.9%
(HRMY) Gross Margin
(PRTH) Gross Margin
HRMY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Harmony Biosciences Holdings, Inc. reported a gross profit of 152.74M and revenue of 184.73M. Therefore, the gross margin over that period was 82.7%.

PRTH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Priority Technology Holdings, Inc. reported a gross profit of 87.28M and revenue of 224.63M. Therefore, the gross margin over that period was 38.9%.

HRMY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Harmony Biosciences Holdings, Inc. reported an operating income of 56.25M and revenue of 184.73M, resulting in an operating margin of 30.5%.

PRTH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Priority Technology Holdings, Inc. reported an operating income of 32.63M and revenue of 224.63M, resulting in an operating margin of 14.5%.

HRMY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Harmony Biosciences Holdings, Inc. reported a net income of 45.56M and revenue of 184.73M, resulting in a net margin of 24.7%.

PRTH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Priority Technology Holdings, Inc. reported a net income of 8.27M and revenue of 224.63M, resulting in a net margin of 3.7%.